All In MedTech

Device Trial Radar · NCT00614510

SynCardia CardioWest TAH-t Postmarket Surveillance Study

The SynCardia CardioWest Temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study

Last checked: Nov 20, 2026Latest source record: Jul 30, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

196

Actual

Start

Aug 2006

Primary completion

Mar 2015

Study completion Mar 2015

Sponsor

Lead sponsor
SynCardia Systems. LLCNot on our public-company list
Sponsor type
Industry
First posted
Feb 13, 2008

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate that the results achieved in the original pivotal clinical investigation of 81 subjects from five clinical sites are generalizable to new clinical sites that complete the staff training defined in the SynCardia Systems, Inc. Training Manual and who enroll subjects who meet the intended use defined in the product Instructions for Use.

Conditions

  • Biventricular Failure

Interventions

  • CardioWest temporary Total Artificial Heart (TAH-t)Device

    The SynCardia CardioWest temporary Total Artificial Heart (TAH-t) system is a pulsatile biventricular device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation. The system consists of the implantable CardioWest TAH-t and an external console connected by drivelines.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subject survival at 30-days and one-year post transplantTime frame: 30-days and one-year post transplant

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.